$1.47 Billion is the total value of Camber Capital Management LP's 43 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 69.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDadr | $103,425,000 | +0.6% | 1,750,000 | +6.1% | 7.04% | -4.1% |
| SPY | Sell | SPDR S&P 500 ETF TRput | $102,925,000 | -50.1% | 500,000 | -50.0% | 7.01% | -52.5% |
| AZN | New | ASTRAZENECA PLCsponsored adr | $79,638,000 | – | 1,250,000 | +100.0% | 5.42% | – |
| XLV | New | SELECT SECTOR SPDR TRput | $74,390,000 | – | 1,000,000 | +100.0% | 5.06% | – |
| MASI | Sell | MASIMO CORP | $73,606,000 | -17.3% | 1,900,000 | -29.6% | 5.01% | -21.2% |
| MDCO | MEDICINES CO | $71,525,000 | +2.1% | 2,500,000 | 0.0% | 4.87% | -2.6% | |
| ESRX | Buy | EXPRESS SCRIPTS HLDG CO | $66,705,000 | +9.8% | 750,000 | +7.1% | 4.54% | +4.7% |
| CYBX | Buy | CYBERONICS INC | $59,460,000 | +22.1% | 1,000,000 | +33.3% | 4.05% | +16.4% |
| GHDX | GENOMIC HEALTH INC | $58,359,000 | -9.0% | 2,100,000 | 0.0% | 3.97% | -13.3% | |
| SEM | Buy | SELECT MED HLDGS CORP | $56,700,000 | +27.4% | 3,500,000 | +16.7% | 3.86% | +21.5% |
| UAM | UNIVERSAL AMERN CORP NEW | $52,977,000 | -5.2% | 5,234,898 | 0.0% | 3.61% | -9.6% | |
| NUVA | New | NUVASIVE INC | $52,118,000 | – | 1,100,000 | +100.0% | 3.55% | – |
| OFIX | ORTHOFIX INTL N V | $49,680,000 | -7.7% | 1,500,000 | 0.0% | 3.38% | -12.0% | |
| JNJ | New | JOHNSON & JOHNSONcall | $48,730,000 | – | 500,000 | +100.0% | 3.32% | – |
| CI | New | CIGNA CORPORATION | $48,600,000 | – | 300,000 | +100.0% | 3.31% | – |
| LH | LABORATORY CORP AMER HLDGS | $48,488,000 | -3.9% | 400,000 | 0.0% | 3.30% | -8.3% | |
| ARIA | Sell | ARIAD PHARMACEUTICALS INC | $47,553,000 | -17.6% | 5,750,000 | -17.9% | 3.24% | -21.4% |
| ARNA | ARENA PHARMACEUTICALS INC | $34,800,000 | +6.2% | 7,500,000 | 0.0% | 2.37% | +1.2% | |
| SQNM | SEQUENOM INC | $27,360,000 | -23.0% | 9,000,000 | 0.0% | 1.86% | -26.6% | |
| XRAY | New | DENTSPLY INTL INC NEW | $25,775,000 | – | 500,000 | +100.0% | 1.76% | – |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $24,600,000 | -12.4% | 10,000,000 | -16.7% | 1.68% | -16.5% |
| PRGO | New | PERRIGO CO PLC | $22,688,000 | – | 122,748 | +100.0% | 1.54% | – |
| KND | Sell | KINDRED HEALTHCARE INC | $22,319,000 | -37.5% | 1,100,000 | -26.7% | 1.52% | -40.3% |
| CCRN | Buy | CROSS CTRY HEALTHCARE INC | $18,941,000 | +12.3% | 1,493,765 | +5.0% | 1.29% | +7.1% |
| NKTR | New | NEKTAR THERAPEUTICS | $18,765,000 | – | 1,500,000 | +100.0% | 1.28% | – |
| DGX | New | QUEST DIAGNOSTICS INC | $18,130,000 | – | 250,000 | +100.0% | 1.23% | – |
| BIOS | Buy | BIOSCRIP INC | $16,880,000 | +27.0% | 4,650,000 | +55.0% | 1.15% | +21.1% |
| New | INNOCOLL AGsponsored adr | $16,344,000 | – | 1,111,111 | +100.0% | 1.11% | – | |
| PLX | New | PROTALIX BIOTHERAPEUTICS INC | $14,185,000 | – | 7,274,577 | +100.0% | 0.97% | – |
| VCYT | New | VERACYTE INC | $13,669,000 | – | 1,226,994 | +100.0% | 0.93% | – |
| ANGO | Buy | ANGIODYNAMICS INC | $12,060,000 | -6.9% | 735,383 | +0.9% | 0.82% | -11.2% |
| DRRX | New | DURECT CORP | $11,950,000 | – | 5,000,000 | +100.0% | 0.81% | – |
| CATB | New | CATABASIS PHARMACEUTICALS IN | $11,326,000 | – | 927,609 | +100.0% | 0.77% | – |
| EPRSQ | EPIRUS BIOPHARMACEUTICALS IN | $10,549,000 | -36.2% | 1,847,500 | 0.0% | 0.72% | -39.2% | |
| BIOL | Sell | BIOLASE INC | $9,278,000 | -17.8% | 5,332,394 | -27.8% | 0.63% | -21.6% |
| GNMK | Sell | GENMARK DIAGNOSTICS INC | $9,222,000 | -52.1% | 1,017,897 | -31.3% | 0.63% | -54.3% |
| NVTA | Buy | INVITAE CORP | $7,440,000 | +11.0% | 500,000 | +25.0% | 0.51% | +5.8% |
| OSUR | Buy | ORASURE TECHNOLOGIES INC | $7,004,000 | +23.9% | 1,299,475 | +50.4% | 0.48% | +18.1% |
| New | PROTALIX BIOTHERAPEUTICS INCnote 4.500% 9/1 | $6,960,000 | – | 9,000,000 | +100.0% | 0.47% | – | |
| KERX | Sell | KERYX BIOPHARMACEUTICALS INC | $4,990,000 | -86.9% | 500,000 | -83.3% | 0.34% | -87.5% |
| TRGT | TARGACEPT INC | $4,352,000 | -6.1% | 1,560,000 | 0.0% | 0.30% | -10.6% | |
| CRDC | CARDICA INC | $4,179,000 | -20.8% | 8,374,846 | 0.0% | 0.28% | -24.4% | |
| BIOL | New | BIOLASE INCcall | $82,000 | – | 1,841,173 | +100.0% | 0.01% | – |
| INO | Exit | INOVIO PHARMACEUTICALS INC | $0 | – | -250,000 | -100.0% | -0.15% | – |
| Exit | PROTALIX BIOTHEAPEUTICS INC | $0 | – | -2,000,000 | -100.0% | -0.25% | – | |
| PLX | Exit | PROTALIX BIOTHERAPEUTICS INCnote 4.500% 9/1 | $0 | – | -9,000,000 | -100.0% | -0.49% | – |
| MDRX | Exit | ALLSCRIPTS HEALTHCASE SOLUTN | $0 | – | -1,000,000 | -100.0% | -0.85% | – |
| TRVN | Exit | TREVENA INC | $0 | – | -2,870,000 | -100.0% | -1.34% | – |
| CNMD | Exit | CONMED CORP | $0 | – | -670,943 | -100.0% | -2.42% | – |
| BRKR | Exit | BRUKER CORP | $0 | – | -2,000,000 | -100.0% | -2.64% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -750,000 | -100.0% | -3.14% | – |
| AMAG | Exit | AMAG PHARACEUTICALS INC | $0 | – | -1,018,246 | -100.0% | -3.97% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEVA PHARMACEUTICALS INDS LTD | 34 | Q3 2023 | 9.7% |
| BROOKDALE SR LIVING INC | 32 | Q3 2023 | 5.0% |
| PERRIGO CO PLC | 29 | Q3 2023 | 7.1% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 8.5% |
| NEKTAR THERAPEUTICS | 28 | Q1 2022 | 9.8% |
| UNIVERSAL HLTH SVCS INC | 25 | Q3 2023 | 9.9% |
| MYRIAD GENETICS INC | 24 | Q3 2023 | 5.0% |
| SAREPTA THERAPEUTICS INC | 23 | Q3 2023 | 6.0% |
| MYLAN NV | 21 | Q3 2020 | 10.1% |
| AMAG PHARMACEUTICALS INC | 21 | Q3 2020 | 4.0% |
View Camber Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC | February 02, 2023 | ? | ? |
| Solid Biosciences Inc. | December 12, 2022 | ? | ? |
| AVROBIO, Inc. | February 14, 2022 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 14, 2022 | ? | ? |
| AMAG PHARMACEUTICALS, INC. | February 16, 2021 | ? | ? |
| Atara Biotherapeutics, Inc. | February 16, 2021 | ? | ? |
| Change Healthcare Inc. | February 16, 2021 | ? | ? |
| GLYCOMIMETICS INC | February 16, 2021 | ? | ? |
| Clovis Oncology, Inc. | February 14, 2020 | ? | ? |
| Cyclerion Therapeutics, Inc. | February 14, 2020 | ? | ? |
View Camber Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-30 |
| 13F-HR | 2023-08-14 |
View Camber Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.